HDAC2 and hepatocellular carcinoma: In addition, the decreased level of Ac-K was restored by treatment with 2 μm trichostatin A (TSA), an inhibitor of histone deacetylase, in IP-WB, signifying that HDAC2 could promote FOXA3 deacetylation in HCC cells (Fig. 6e).